Based in Princeton, New Jersey, NeoStrata has developed and marketed ranges “clinically-proven, dermatologist-developed, skin care products that meet the needs of every skin type” since its creation in 1988. The company’s brands include: Exuviance, Coverblend and NeoStrata.
Johnson & Johnson (J&J), which produces brands such as Johnson’s Baby, Band-Aid, Neutrogena, Tylenol, Motrin, and Listerine, intends to complement its global portfolio of advanced skin care brands.
“NeoStrata and Johnson & Johnson share a strong history of innovation and together we will work to discover important new skin care solutions grounded in deep human insights and compelling science. We look forward to working closely with NeoStrata’s distributors around the world and having their outstanding team of employees join Johnson & Johnson Consumer later this year,” said Jorge Mesquita, Worldwide Chairman, Consumer, Johnson & Johnson.
The acquisition, which is subject to clearance by antitrust authorities, will include NeoStrata’s affliates and parent company TriStrata and is expected to close in the first half of 2016. Financial terms were not disclosed.